Cargando…

Reprogramming of Melanoma Tumor-Infiltrating Lymphocytes to Induced Pluripotent Stem Cells

Induced pluripotent stem cells (iPSCs) derived from somatic cells of patients hold great promise for autologous cell therapies. One of the possible applications of iPSCs is to use them as a cell source for producing autologous lymphocytes for cell-based therapy against cancer. Tumor-infiltrating lym...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saito, Hidehito, Okita, Keisuke, Fusaki, Noemi, Sabel, Michael S., Chang, Alfred E., Ito, Fumito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707343/ https://www.ncbi.nlm.nih.gov/pubmed/27057178 http://dx.doi.org/10.1155/2016/8394960

Ejemplares similares

Reprogramming of Tumor-reactive Tumor-infiltrating Lymphocytes to Human-induced Pluripotent Stem Cells
por: Islam, S.M. Rafiqul, et al.
Publicado: (2023)

BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytes
por: Peiffer, Lukas, et al.
Publicado: (2020)

Tumor-infiltrating lymphocytes for melanoma immunotherapy
por: Kepp, Oliver, et al.
Publicado: (2023)

Prevention of tumor risk associated with the reprogramming of human pluripotent stem cells
por: Wuputra, Kenly, et al.
Publicado: (2020)

Role of tumor suppressor genes in the cancer-associated reprogramming of human induced pluripotent stem cells
por: Lin, Ying-Chu, et al.
Publicado: (2014)

Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome
por: Fusaki, Noemi, et al.
Publicado: (2009)

The antigen specific composition of melanoma tumor infiltrating lymphocytes?
por: Hadrup, Sine Reker
Publicado: (2012)

Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
por: Fortes, Cristina, et al.
Publicado: (2015)

Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma
por: Maibach, Fabienne, et al.
Publicado: (2020)

Tumor-Infiltrating Lymphocyte Therapy in Melanoma: Facts to the Future
por: Betof Warner, Allison, et al.
Publicado: (2023)

KLF4 N-Terminal Variance Modulates Induced Reprogramming to Pluripotency
por: Kim, Shin-Il, et al.
Publicado: (2015)

Correction: Generation of Virus-Free Induced Pluripotent Stem Cell Clones on a Synthetic Matrix via a Single Cell Subcloning in the Naïve State
por: Nishishita, Naoki, et al.
Publicado: (2012)

Expansion and Characterization of Human Melanoma Tumor-Infiltrating Lymphocytes (TILs)
por: Nguyen, Linh T., et al.
Publicado: (2010)

Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma
por: Sarnaik, Amod A., et al.
Publicado: (2021)

Poor Lymphocyte Infiltration to Primary Tumors in Acral Lentiginous Melanoma and Mucosal Melanoma Compared to Cutaneous Melanoma
por: Nakamura, Yoshiyuki, et al.
Publicado: (2020)

Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration
por: El Khatib, Moustafa M., et al.
Publicado: (2016)

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients
por: Saint-Jean, Mélanie, et al.
Publicado: (2018)

An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma
por: Acs, Balazs, et al.
Publicado: (2019)

De Novo DNA Methylation at Imprinted Loci during Reprogramming into Naive and Primed Pluripotency
por: Yagi, Masaki, et al.
Publicado: (2019)

Reprogramming Primordial Germ Cells into Pluripotent Stem Cells
por: Durcova-Hills, Gabriela, et al.
Publicado: (2008)

Clinical results of combined vemurafenib and tumor-infiltrating lymphocyte therapy for metastatic melanoma
por: Sarnaik, Amod, et al.
Publicado: (2015)

Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option
por: Rohaan, Maartje W., et al.
Publicado: (2018)

Optimization of an automated tumor-infiltrating lymphocyte algorithm for improved prognostication in primary melanoma
por: Chou, Margaret, et al.
Publicado: (2020)

Addressing the importance of melanoma tumor-infiltrating lymphocytes in disease progression and clinicopathological characteristics
por: Zablocka, Tatjana, et al.
Publicado: (2021)

Reprogramming of spermatogonial stem cells into pluripotent stem cells in the spheroidal state
por: Lee, Yukyeong, et al.
Publicado: (2019)

Linking Incomplete Reprogramming to the Improved Pluripotency of Murine Embryonal Carcinoma Cell-Derived Pluripotent Stem Cells
por: Chang, Gang, et al.
Publicado: (2010)

The Clinical Significance of Tumor-Infiltrating Lymphocytes and Microscopic Satellites in Acral Melanoma in a Korean Population
por: Lee, Seok-Jong, et al.
Publicado: (2013)

Induced pluripotent stem cells free of exogenous reprogramming factors
por: Abujarour, Ramzey, et al.
Publicado: (2009)

Two Factor Reprogramming of Human Neural Stem Cells into Pluripotency
por: Hester, Mark E., et al.
Publicado: (2009)

Reprogramming to Pluripotency through a Somatic Stem Cell Intermediate
por: Marthaler, Adele G., et al.
Publicado: (2013)

Dissecting microRNA-mediated regulation of stemness, reprogramming, and pluripotency
por: Lee, Young Jin, et al.
Publicado: (2016)

Reprogramming of Mouse Calvarial Osteoblasts into Induced Pluripotent Stem Cells
por: Wang, Yinxiang, et al.
Publicado: (2018)

Partial Reprogramming of Pluripotent Stem Cell-Derived Cardiomyocytes into Neurons
por: Chuang, Wenpo, et al.
Publicado: (2017)

Reprogramming of Cancer Cells into Induced Pluripotent Stem Cells Questioned
por: Bang, Jin Seok, et al.
Publicado: (2019)

Chromosomal aberrations after induced pluripotent stem cells reprogramming
por: Vaz, Isadora May, et al.
Publicado: (2021)

Generation and Characterization of Induced Pluripotent Stem Cells from Aid-Deficient Mice
por: Shimamoto, Ren, et al.
Publicado: (2014)

Tumor-infiltrating lymphocyte: features and prognosis of lymphocytes infiltration on colorectal cancer
por: Qin, Miao, et al.
Publicado: (2023)

Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma
Publicado: (1988)

Effects of Ipilimumab on expanded tumor infiltrating lymphocytes in patients with stage IV malignant melanoma
por: Bjørn, Jon, et al.
Publicado: (2013)

Tumor-Infiltrating CD8+ Lymphocytes Effect on Clinical Outcome of Muco-Cutaneous Melanoma
por: Rahbar, Mahtab, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qspp58pmkq98qv2ocd3d11ligo